Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Medtech Ventures | Drug Eluting Coronary Stents Market - Current Situation & Future Outlook

Drug Eluting Coronary Stents Market - Current Situation & Future Outlook

The Market for Drug Eluting Coronary Stents grew by 3% in 2008 reaching $4.2 Billion globally. Decline in average selling price was offset by growth in procedure volume and improved penetration levels.

The US market remained stable at $1.8 billion accounting for 43% of the world market. The launch of Medtronic's Endeavor zotarolimus-eluting stent and Abbott's & Boston Scientific's Xience and Promus everolimus-eluting stents during the year, redistributed market shares with JnJ's Cypher losing the most.

The market for drug eluting coronary stents is exhibiting clear evidence of recovery with average annual PCI volumes rising by 5% in the US and 4% in Europe. Average penetration rates are also rising in all markets.

Drug Eluting Coronary Stents Market - Current Situation & Future Outlook is a New 2009 Edition of Medtech Ventures' best selling report. The report offers a timely analysis of the latest happenings with market revenue and growth rates for main regions, up-to-date market shares for leading companies and brands and market forecasts to 2015.

With Drug Eluting Coronary Stents Market - Current Situation & Future Outlook, you'll be able to:

Understand current market dynamics, competitor positions and market shares.

Assess market size and growth potential for these combined drug devices.

Monitor the competition's marketed and in-development products.

Identify emerging technologies and the companies behind them.

Assess market potential and have access to forecasts till 2015.

Leverage your own technology and brain storm new business opportunities.

Investigate mergers, acquisitions and licensing possibilities

Report Code: MV09023

Report Publisher: Medtech Ventures

Date Published: February 2009

Number of Pages: 40

Report Price:

PDF file by email: $2,450

Site License: $4,900

View Table of Contents...

Price

PDF Single User $2450.00

PDF Site Licence $4900.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions